Understanding EndoBarrier Therapy, a breakthrough in Type 2 Diabetes
Clinical studies have shown that up to 85% of patients are able to reach healthy blood sugar levels AND lose up to 20% of their total body weight within 12 months. These results may lead to a reduction in diabetes medications, including insulin.
This website is not intended for a U.S. audience. This website describes a product, which has not been approved or cleared for marketing by the U.S. Food and drug administration and is not available in the United States. Please visit our clinical trial website.
Please use the drop down menu below to visit the information page that matches your country of residence.